Compare ARK Genomic Revolution ETF (ARKG) vs Mondaycom Ltd (MNDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Mondaycom Ltd — how do they compare? ARK Genomic Revolution ETF trades at $40.8, while Mondaycom Ltd trades at $87.01 (market cap $3.54B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Mondaycom Ltd nearer its low. Which is the better fit depends on your goals.
| ARKG | MNDY | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $292.24 |
52-Week Low | $23.09 | $58.81 |
Market Cap | — | $3.54B |
Enterprise Value | — | $2.50B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Monday.com (MNDY) trades at $82.47, down 1.41% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $116.75. The company reported strong revenue of $1.23 billion in 2025 and has beaten EPS estimates for three consecutive quarters, though its EV/EBITDA of 110.73 indicates high valuation expectations. Recent news highlights investor interest despite stock volatility, with the Motley Fool noting the dip may present a buying opportunity.
The outlook for MNDY is positive based on analyst sentiment and earnings performance, but risks include elevated valuation multiples and competitive pressures in the SaaS sector. Investors should weigh the company's robust growth against potential market volatility and execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Mondaycom Ltd
Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.
Read more on MNDY →
